Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1836440
Disease: Increased serum lactate
Increased serum lactate
0.100 Biomarker phenotype HPO
CUI: C1848701
Disease: Elevated hepatic transaminase
Elevated hepatic transaminase
0.100 Biomarker phenotype HPO
CUI: C1850415
Disease: Microvesicular hepatic steatosis
Microvesicular hepatic steatosis
0.100 Biomarker phenotype HPO
CUI: C1856432
Disease: Dicarboxylic aciduria
Dicarboxylic aciduria
0.100 Biomarker phenotype HPO
CUI: C1858120
Disease: Generalized hypotonia
Generalized hypotonia
0.100 Biomarker phenotype HPO
CUI: C1865292
Disease: Nonketotic hypoglycemia
Nonketotic hypoglycemia
0.100 Biomarker phenotype HPO
Decreased activity of mitochondrial complex I
0.100 Biomarker phenotype HPO
CUI: C2711227
Disease: Steatohepatitis
Steatohepatitis
0.100 Biomarker disease HPO
CUI: C4021726
Disease: EMG: myopathic abnormalities
EMG: myopathic abnormalities
0.100 Biomarker phenotype HPO
Elevated creatine kinase after exercise
0.100 Biomarker phenotype HPO
Elevated plasma acylcarnitine levels
0.100 Biomarker phenotype HPO
Increased lactate dehydrogenase activity
0.100 Biomarker phenotype HPO
CUI: C4552811
Disease: Generalized Muscle Weakness, CTCAE
Generalized Muscle Weakness, CTCAE
0.100 Biomarker phenotype HPO
CUI: C0162666
Disease: Mitochondrial Encephalomyopathies
Mitochondrial Encephalomyopathies
0.010 GeneticVariation disease BEFREE Mitochondrial encephalomyopathy due to a novel mutation in ACAD9. 23836383 2013
CUI: C0878544
Disease: Cardiomyopathies
Cardiomyopathies
0.030 GeneticVariation group BEFREE ACAD9 is an acyl-CoA dehydrogenase with a novel function in assembly of complex I; biallelic mutations cause progressive encephalomyopathy, recurrent Reye syndrome, and fatal cardiomyopathy. 26826406 2016
CUI: C0027765
Disease: nervous system disorder
nervous system disorder
0.010 Biomarker group BEFREE ACAD9-mutated patients have been reported to suffer from primarily heart, muscle, liver, and nervous system disorders. 27233227 2016
Nicotinamide adenine dinucleotide coenzyme Q reductase deficiency
0.090 GeneticVariation disease BEFREE ACAD9 mutation is suspected in cases of elevated lactic acid levels combined with complex I deficiency, and confirmed by ACAD9 gene analysis. 27233227 2016
Nicotinamide adenine dinucleotide coenzyme Q reductase deficiency
0.090 GeneticVariation disease BEFREE ACAD9 is an assembly factor for the mitochondrial respiratory chain complex I. ACAD9 mutations are recognized as frequent causes of complex I deficiency. 28279569 2017
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 20
0.600 GeneticVariation disease UNIPROT A Comprehensive Genomic Analysis Reveals the Genetic Landscape of Mitochondrial Respiratory Chain Complex Deficiencies. 26741492 2016
Acyl-CoA Dehydrogenase Family, Member 9, Deficiency of
0.610 Biomarker disease CLINGEN A new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9 deficiency. 17564966 2007
Acyl-CoA Dehydrogenase Family, Member 9, Deficiency of
0.610 GermlineCausalMutation disease ORPHANET A new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9 deficiency. 17564966 2007
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 20
0.600 Biomarker disease GENOMICS_ENGLAND A new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9 deficiency. 17564966 2007
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 20
0.600 GeneticVariation disease UNIPROT A new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9 deficiency. 17564966 2007
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 20
0.600 Biomarker disease GENOMICS_ENGLAND A new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9 deficiency. 17564966 2007
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 20
0.600 GeneticVariation disease UNIPROT A Patient with Complex I Deficiency Caused by a Novel ACAD9 Mutation Not Responding to Riboflavin Treatment. 23996478 2014